Head-to-head comparison
| Property | GHK-Cu | Epithalon |
|---|---|---|
| Category | Skin & Beauty | Longevity |
| Legal Status | Unregulated | Research Only |
| Primary Route | topical | subcutaneous |
| Half-life | ~1 hour (plasma) | ~2-3 hours (estimated) |
| Mol. Weight | 403.93 Da | 390.35 Da |
| Side Effects | Injection site irritation, Skin redness (topical), Mild stinging (topical) | Injection site discomfort, Mild flu-like symptoms (rare), Drowsiness |
Key differences
- Anti-aging mechanism: GHK-Cu promotes collagen/elastin synthesis and wound healing for visible skin rejuvenation; epithalon is proposed to activate telomerase to extend telomere length for cellular longevity.
- Application type: GHK-Cu is primarily a cosmetic/dermatological peptide (topical serums and creams); epithalon is a systemic peptide typically administered subcutaneously.
- Evidence quality: GHK-Cu has published human studies in dermatology and wound care; epithalon's evidence comes primarily from Khavinson's Russian research with limited Western peer-reviewed replication.
- Availability: GHK-Cu is widely available over-the-counter in skincare products; epithalon is available as a research compound.
- Molecular size: GHK-Cu is a tripeptide (3 amino acids + copper ion, ~340 Da); epithalon is a tetrapeptide (4 amino acids, ~390 Da).
- Primary outcome: GHK-Cu aims for visible skin improvement (wrinkles, texture, wound healing); epithalon aims for systemic cellular aging reversal (telomere maintenance, pineal function).
- Safety data: GHK-Cu has a well-established safety profile from cosmetic use; epithalon safety is supported primarily by Khavinson laboratory studies and limited clinical data.
The verdict
GHK-Cu and epithalon target anti-aging at different levels: GHK-Cu for visible, topical skin rejuvenation with solid human evidence, and epithalon for systemic cellular longevity with more speculative evidence. GHK-Cu is the more evidence-supported and accessible option for cosmetic anti-aging. Epithalon is of interest for longevity researchers but requires more independent clinical validation. They are complementary rather than competing — different levels of the anti-aging hierarchy.
Frequently asked questions
They target entirely different anti-aging mechanisms — GHK-Cu for skin collagen/wound healing and epithalon for telomerase activation. There is no known interaction. Some longevity protocols discuss using both as complementary approaches addressing different levels of aging.
GHK-Cu is specifically studied for skin rejuvenation with human clinical evidence for collagen stimulation, wrinkle reduction, and skin thickness improvement. Epithalon's proposed anti-aging mechanism operates at the cellular/telomere level and is not specifically studied for cosmetic skin outcomes.
Epithalon has shown lifespan extension in animal models in Khavinson's research, and is proposed to work by activating telomerase and supporting pineal function. However, these results have limited independent Western replication, and no human longevity trials exist. The evidence is promising but preliminary.
Yes, GHK-Cu is widely available in over-the-counter skincare products including serums, creams, and masks. It is one of the most commercially accessible peptides. Epithalon is not available as a consumer product and must be obtained as a research compound.
GHK-Cu has stronger evidence by Western peer-review standards, with published human clinical studies in dermatology and wound care across multiple independent research groups. Epithalon's evidence comes primarily from one research group (Khavinson Institute) with limited independent replication.